https://www.selleckchem.com/products/azd8186.html
This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.INTRODUCTION Our aim in this study was to determine whether intravenous immunoglobulin (IVIg) or plasma exchange (PLEx) for treatment of neurologic disease is a trigger for thrombotic events. METHODS Using administrative data from 2005 to 2014, we identified index admissions for thrombotic events. We performed case-crossover analyses for these admissions with previous admissions for neurologic disease with IVIg or PLE
Like
Comment
Share
